Doxycycline for Clinical Management of Filarial Lymphedema (Sri Lanka)

Determine whether doxycycline treatment daily for 6 weeks improves clinical outcomes (swelling, acute attacks) in lymphedema patients.

Sites

Implementation partner(s): Sri Lanka MOH
WHO Region: SEARO

Publications

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis

Horton, J., Klarmann-Schulz, U., Stephens, M. et al.
2020, Issue no. 13, pages 155

Notes

This project is associated with Doxycycline for Clinical Management of Filarial Lymphedema (India) and Doxycycline for Clinical Management of Filarial Lymphedema (Mali).

The National Clinical Trials registry number for this project is NCT02929134.

 

 

Email primary contact

Please log in or register